Sai Life Sciences Limited (NSE:SAILIFE)

Sai Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 7, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	204,292	158,581	-	-	-	-
Enterprise Value	205,406	166,413	-	-	-	-
Last Close Price	967.15	760.85	-	-	-	-
PE Ratio	70.92	93.21	-	-	-	-
Forward PE	57.74	72.51	-	-	-	-
PS Ratio	9.95	9.36	-	-	-	-
PB Ratio	9.00	7.45	-	-	-	-
P/TBV Ratio	9.04	7.49	-	-	-	-
P/OCF Ratio	66.87	50.50	-	-	-	-
EV/Sales Ratio	10.00	9.82	-	-	-	-
EV/EBITDA Ratio	38.18	46.28	-	-	-	-
EV/EBIT Ratio	51.54	61.49	-	-	-	-
Debt / Equity Ratio	0.18	0.17	0.95	1.05	1.10	0.78
Debt / EBITDA Ratio	0.78	0.88	3.28	5.80	8.18	4.12
Debt / FCF Ratio	-	-	11.40	8.77	-	-
Asset Turnover	0.71	0.62	0.66	0.56	0.44	-
Inventory Turnover	5.41	4.97	4.27	3.50	3.04	-
Quick Ratio	1.03	1.58	1.05	0.93	0.99	1.05
Current Ratio	1.92	2.05	1.28	1.27	1.32	1.34
Return on Equity (ROE)	17.28%	10.96%	8.89%	1.13%	0.71%	-
Return on Assets (ROA)	8.58%	6.22%	4.83%	1.90%	0.98%	-
Return on Capital (ROIC)	10.54%	7.72%	5.78%	2.25%	1.15%	-
Return on Capital Employed (ROCE)	15.60%	11.10%	11.20%	4.60%	2.10%	7.10%
Earnings Yield	1.40%	1.07%	-	-	-	-
FCF Yield	-0.97%	-0.35%	-	-	-	-
Buyback Yield / Dilution	-13.02%	-8.04%	-0.27%	-0.46%	-5.32%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.